ZELTIQ Aesthetics acquired by Allergan

Allergan acquired ZELTIQ Aesthetics, a US medical aesthetics / body contouring devices brand, on Apr 28, 2017.

Transaction summary

Target
ZELTIQ Aesthetics
Acquirer
Allergan
Seller
-
Announced
2017-02-13
Geography
United States
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-06-19
Latest update
2026-10-21

Value and multiples

100% enterprise value

USD 2.5B

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

6.2x

Period not stated

Basis: FundComb estimate

EV / EBITDA

-

EBITDA basis not stated

Basis: FundComb estimate

Amounts paid and other reported values

Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.

Consideration: USD 2.5B

Public Google News result for PR Newswire headline states Allergan to acquire ZELTIQ for $2.47 billion; other headlines cite approximately $2.48 billion.

Basis

  • Allergan announced the acquisition for USD 2.47bn (PR Newswire, 13 February 2017); other reports cite about USD 2.48bn. The 6.2x revenue multiple comes from FundComb’s comps spreadsheet and is not confirmed by a public source; the revenue and period behind it are not stated.

Source summary

Allergan to Acquire ZELTIQ, Best-in-Class Company in Fast-Growing Body Contouring Segment, for $2.47 Billion - PR Newswire

Confirmed
Open via Google News

Continue your research

Explore more comps →